Savvy Advisors Inc’s CervoMed CRVO Stock Holding History

Savvy Advisors Inc’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$80.4K	Hold	25,922	–	–	﹤0.01%	1233
2026 Q1	$102K	Hold	25,922	–	–	﹤0.01%	1106
2025 Q4	$205K	Hold	25,922	–	–	0.01%	949
2025 Q3	$210K	Buy	+25,922	New	+$222K	0.01%	770

Other funds holding CRVO

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAM

Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return

CFG

Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TDC

Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return

Savvy Advisors Inc's CRVO Position: Q2 2026 in Review

Savvy Advisors Inc held its CervoMed (CRVO) position steady in Q2 2026 at 25,922 shares worth $80.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1233.

Savvy Advisors Inc first reported a position in CRVO in Q3 2025 and has held it in 4 quarters since. The position peaked at $210K in Q3 2025. 37 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

Savvy Advisors Inc held 25,922 shares of CervoMed worth $80.4K as of Q2 2026.
Savvy Advisors Inc left its CervoMed share count unchanged in Q2 2026.
CervoMed made up ﹤0.01% of Savvy Advisors Inc's portfolio in Q2 2026, its #1233 holding.
Savvy Advisors Inc first reported a position in CervoMed in Q3 2025 and has held it in 4 quarters since.
Savvy Advisors Inc's CervoMed position peaked at $210K in Q3 2025.
37 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on Savvy Advisors Inc's 13F filing for Q2 2026, filed 3 Aug 2026.